|
SE
|
CI 95%
|
SP
|
IC 95%
|
PPV
|
IC 95%
|
NPV
|
IC 95%
|
---|
ALDH1
| | | | | | | | |
TFS n = 25
|
84%
|
0.63-0.94
|
98.8%
|
0.95-0.99
|
91.3%
|
0.7-0.98
|
97.6%
|
0.93-0.99
|
HPC = 55
|
85.4%
|
0.73-0.93
|
98.7%
|
0.95-0.99
|
95.9%
|
0.84-0.99
|
95.2%
|
0.9-0.97
|
CD34
| | | | | | | | |
TFS n = 25
|
92%
|
0.72-0.98
|
95%
|
0.9-0.97
|
74.2%
|
0.55-0.87
|
98.7%
|
0.94-0.99
|
HPC n = 55
|
74.5%
|
0.61-0.85
|
95%
|
0.9-0.97
|
83.7%
|
0.69-0.92
|
91.7%
|
0.86-0.95
|
ALDH1 and CD34+
| | | | | | | | |
TFS n = 20
|
80%
|
0.58-0.92
|
100%
|
0.97-1
|
100%
|
0.79-1
|
97%
|
0.93-0.99
|
HPC n = 34
|
62%
|
0.48-0.74
|
100%
|
0.97-1
|
100%
|
0.87-1
|
88%
|
0.83-0.93
|
- SE: sensitivity, PPV: positive predictive value.
- SP: specificity, NPV: negative positive value.